Donanemab: Not two without a third.

Overview of attention for article published in Advances in Clinical and Experimental Medicine, October 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#12 of 640)
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Dimensions has found 4 publications that cite this research output.

Article in Journal of Alzheimer's Disease (March 2024)

Article in International Journal of Pharmaceutical Chemistry and Analysis (March 2024)

Article in Current Alzheimer Research (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.